Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma-Reference-Cited by-同舟云学术

Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma

Published:2013-07-02 Issue:9 Volume:139 Page:1489-1498
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Chantzi Νiki Ι.,Tiniakos Dina G.,Palaiologou Marina,Goutas Nikolaos,Filippidis Theodoros,Vassilaros Stamatis D.,Dhimolea Eugen,Mitsiou Dimitra J.,Alexis Μichael N.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-013-1467-4.pdf

Reference38 articles.

1. Chantzi NI, Meligova AK, Dhimolea E, Petrou CC, Mitsiou DJ, Magafa V, Pechtelidou A, Florentin I, Kitraki E, Cordopatis P, Tiniakos DG, Alexis MN (2011) Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β. Steroids 76:974–985. doi: 10.1016/j.steroids.201105010

2. Dey P, Jonsson P, Hartman J, Williams C, Ström A, Gustafsson JÅ (2012) Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Mol Endocrinol 26:1991–2003. doi: 10.1210/me.20121227

3. Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA, Rochefort H (2005) Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin Cancer Res 11:3170–3174. doi: 10.1158/10780432CCR042298

4. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S (2001) Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochem Biophys Res Commun 289:692–699. http://dx.doi.org/10.1006/bbrc.2001.6038

5. Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Eden P, Peterson C, Malmstrom P, Isola J, Borg A, Ferno M (2007) Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin Cancer Res 13:1987–1994. doi: 10.1158/1078-0432.CCR-06-1823

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor;Receptors;2024-05-03

2. Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research;Frontiers in Cell and Developmental Biology;2023-10-23

3. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid;International Journal of Molecular Sciences;2023-02-13

4. Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression;Pharmacology & Therapeutics;2023-02

5. Therapeutic potentials of genistein: New insights and perspectives;Journal of Food Biochemistry;2022-05-17